Cabot (CBT) | Stock Overview & Key Data
Cabot Performance Comparison
Stock Range
Today's Range
Low: $79.64
High: $83.70
on August 22, 2025
52 Week Range
Low: $70.41
High: $117.46
on August 1, 2025
on November 7, 2024
All-Time High: $117.46 on November 4, 2024
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$4.2B
EPS
7.64
P/E Ratio (TTM)
10.35
Forward P/E
9.33
P/B Ratio
2.73
PEG Ratio
-1.74
Div. Yield
1.18%
ROE
29.44%
Beta
0.858
Debt to Equity
72.97
Financial Highlights
Profitability
Gross Margin
26.44%
Operating Margin
18.09%
Profit Margin
11.14%
Returns and Earnings
Return on Assets (TTM)
10.92%
Return on Equity (TTM)
29.44%
EBITDA
$811.0M
Net Income (TTM)
$418.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$70.26
Quarterly Revenue Growth (YoY)
-9.20%
Quarterly Earnings Growth (YoY)
-7.30%
Dividend Information
Last 12-Month Dividend
$0.86
Current Dividend Yield
1.18%
3-Year Average Dividend Yield
0.48%
3-Year Average Annual Dividend
$1.20
3-Year Total Dividends
$3.60
Ex-Dividend Date
November 29, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Cabot CBT | 4.21B Mid-cap | 6.13% | 7.69% | 12.01% | -2.30% | -6.68% | -20.42% | 10.67% | 115.40% |
| Linde plc LIN | 222.60B Mega-cap | 0.33% | 2.04% | 4.94% | 5.05% | 16.30% | 3.42% | 68.27% | 89.96% |
| Sherwin-Williams SHW | 91.45B Large-cap | 2.38% | 9.71% | 5.71% | 8.49% | 11.98% | 3.96% | 58.22% | 65.53% |
| Albemarle ALB | 9.85B Mid-cap | 8.89% | 17.38% | 36.26% | -1.66% | -3.57% | 3.55% | -69.56% | -8.41% |
| Eastman Chemical EMN | 7.58B Mid-cap | 5.92% | -12.18% | -14.65% | -29.31% | -21.55% | -31.11% | -26.94% | -6.70% |
| NewMarket NEU | 7.41B Mid-cap | 3.98% | 9.73% | 23.12% | 43.57% | 56.04% | 41.50% | 176.97% | 116.40% |
Ownership & Short Interest
Insider Ownership
1.22%
Institutional Ownership
98.13%
Shares Short
2M
Short Ratio
6.31
Short % of Shares Outstanding
5.52%
Average 10-Day Volume
361K
Average 90-Day Volume
396K
Cabot Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Cabot would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CBT's 52-week high and low?
- In the last 52 weeks, Cabot reached a high of $117.46 (on November 7, 2024) and a low of $70.41 (on August 1, 2025).
- What is the market cap and P/E ratio for CBT?
- Curious about Cabot's size and valuation? Its market capitalization stands at 4.21B. When it comes to valuation, the P/E ratio (trailing twelve months) is 10.35, and the forward P/E (looking ahead) is 9.33.
- Does CBT pay dividends? If so, what's the yield?
- Yes, Cabot is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.18%, and the company has paid an average of $1.20 per share annually over the past 3 years.
- Who are Cabot's main competitors or similar companies to consider before investing?
When looking at Cabot, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Linde plc
LIN222.60B Basic Materials Specialty Chemicals 3.42% 68.27% Sherwin-Williams
SHW91.45B Basic Materials Specialty Chemicals 3.96% 58.22% Albemarle
ALB9.85B Basic Materials Specialty Chemicals 3.55% -69.56% Eastman Chemical
EMN7.58B Basic Materials Specialty Chemicals -31.11% -26.94% NewMarket
NEU7.41B Basic Materials Specialty Chemicals 41.50% 176.97% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Cabot Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Cabot's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 29.44%, the Debt to Equity ratio from the most recent quarter is 72.97, and its Gross Profit Margin stands at 26.44%.
- What is the recent revenue and earnings growth for CBT?
- Looking at Cabot's growth, its revenue over the trailing twelve months (TTM) was $4B. Compared to the same quarter last year (YoY), quarterly revenue grew by -9.20%, and quarterly earnings saw a YoY growth of -7.30%.
- How much of CBT stock is held by insiders and institutions?
- Wondering who owns Cabot stock? Company insiders (like executives and directors) hold about 1.22% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 98.13%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.